About this Event
In today's biotech market, breakthrough science alone is no longer enough. Investors, strategic partners and acquirers are placing greater emphasis on intellectual property as a key indicator of value, defensibility and long-term commercial potential.
Bringing together biotech founders, investors, pharmaceutical business development leaders and IP specialists, this discussion will examine how intellectual property influences fundraising outcomes, deal making and competitive positioning throughout a company's growth journey.
The panel will share practical insights into what investors and partners look for during diligence, how to build an IP strategy that supports enterprise value, and how emerging developments such as AI and changing global regulatory frameworks are reshaping innovation and ownership.
The session will conclude with an audience Q&A and networking.
Panel
- Confirmed: Mike Ward, Chair. Life Science Consultant
- Confirmed: Will Arends, Partner, Marks & Clerk
- Confirmed: Sten Sorensen, CEO, Cereno Scientific
- Confirmed: David Bejker, CEO, Affibody
- Confirmed: Dan Slagel, Head of Strategic Partnerships, Remora Biotech
Further panel members to be announced soon
Discussion Topics
The panel will explore:
- Why intellectual property has become a critical driver of biotech valuation
- How investors assess the strength and commercial relevance of an IP portfolio
- The role of IP strategy in successful Series A and later-stage fundraising
- Common IP and diligence issues that can impact investment decisions
- How biotech companies can create value beyond the next funding round
- The implications of AI, evolving patent landscapes and global regulatory developments for life sciences innovation
- What founders can do today to build a stronger, more investable business
Key Takeaways
Attendees will gain:
- A deeper understanding of how intellectual property influences company valuation and investment decisions
- Insight into current investor expectations in the biotech sector
- Practical guidance on preparing for fundraising and due diligence
- Perspectives from experienced founders, investors and IP specialists
- Actionable strategies for building long-term enterprise value through innovation and IP
Host Organisations
About 59 North...
About One Nucleus...
About M&C...
Event venue & nearby stays
Marks & Clerk, 15 Fetter Lane, London, United Kingdom
Concerts, fests, parties, meetups — all the happenings, one place.